ANGO vs PSA · rev $292.5M vs rev $4.82B
AngioDynamics Inc (ANGO) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
PSA (PSA) common stock.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
ANGO currently screens at market cap $378.5M. PSA currently screens at market cap $0.
Not investment advice. Open the ANGO and PSA stock pages for the full models.
Not investment advice.